A fraction from Escherichia coli with anti-Aspergillus properties

Journal of Medical Microbiology

Volumn 54, Issue 4, 2005, Pages 375-379

  Yadav, V ^a   Mandhan, R ^b   Dabur, Rajesh ^c   Chhillar, A K ^a   Gupta, J ^a   Sharma, G L ^a,c  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b KURUKSHETRA UNIVERSITY   (India)

^c BUNDELKHAND UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; BACTERIUM LYSATE; BACTERIUM LYSATE BL21; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; BACTERIAL MEMBRANE; BACTERIUM ISOLATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ERYTHROCYTE STRUCTURE; ESCHERICHIA COLI; ESCHERICHIA COLI BL21; EVALUATION; GROWTH INHIBITION; HEMOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; ION EXCHANGE CHROMATOGRAPHY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR MODEL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; STRAIN IDENTIFICATION;

ANTIFUNGAL AGENTS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; BACTERIOLOGICAL TECHNIQUES; COCULTURE TECHNIQUES; ESCHERICHIA COLI; FUNGAL PROTEINS; HEMOLYSIS; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 16844372907     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.45748-0     Document Type: Article

References (33)

1. Bottone, E. J. & Peluso, R. W. (2003). Production by Bacillus pumilus (MSH) of an antifungal compound that is active against Mucoraceae and Aspergillus species: preliminary report. J Med Microbiol 52, 69-74.
2. Chiou, C. C., Groll, A. H. & Walsh, T. J. (2000). New drugs and novel targets for treatment of invasive fungal infections in patients with cancer. Oncologists, 120-135.
3. Choi, Y. J., Kim, E. J., Piao, Z., Yun, Y. C. & Shin, Y. C. (2004). Purification and characterization of chitosanase from Bacillus sp. strain KCTC 0377BP and its application for the production of chitosan oligosaccharides. Appl Environ Microbiol 70, 4522-4531.
4. Conlon, J. M., Sonnevend, A., Patel, M., Davidson, C., Nielsen, P. F., Pal, T. & Rollins-Smith, L. A. (2003). Isolation of peptides of the brevinin-1 family with potent candidacidal activity from the skin secretions of the frog Rana boylii. J Pept Res 62, 207-213.
5. Dahot, U. A. (1998). Antimicrobial activity of small protein of Moringa oleifera leaves. J Islam Acad Sci 11(1), 1-5.
6. Dahot, U. M. (1999). Antibacterial and antifungal activity of small protein of Indigofera oblongifolia leaves. J Ethnopharmacol 64, 277-282.
7. Epple, P., Apel, K. & Bohlmann, H. (1997). Overexpression of an endogenous thionin enhances resistance of Arabidopsis against Fusarium oxysporum. Plant Cell 9, 509-520.
8. Georg, K. J. & Schlorer, E. (1998). Probiotic therapy of pseudomembranous colitis. Combination of intestinal lavage and oral administration of Escherichia coli. Dtsch Med Wochenschr 123, 1274-1278 (in German).
9. Georgopapadakou, N. & Walsh, T. (1996). Antifungal agents: chemotherapeutic targets and immunologic stratagies. Antimicrob Agents Chemother 40, 279-291.
10. Graybill, J. R., Bocanegra, R., Najvar, L. K., Loebenberg, D. & Luther, M. F. (1998). Granulocyte colony-stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression. Antimicrob Agents Chemother 42, 2467-2473.
11. Hong, S. Y., Oh, J. E. & Lee, K. H. (1999). In vitro antifungal activity and cytotoxicity of a novel membrane-active peptide. Antimicrob Agents Chemother 43, 1704-1707.
12. Laemmli, U. K. & Favre, M. (1973). Maturation of the head of bacteriophage T4. DNA packaging events. J Mol Biol 80, 575-599.
13. Latoud, C., Peypoux, F., Michael, G., Genat, R. & Morgat, J. (1986). Interaction of antibiotics of the iturin group with human erythrocytes. Biochem Biophys Acta 856, 526-535.
14. Lehrer, R. I., Lichtenstein, A. K. & Ganz, T. (1993). Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 11, 105-128.
15. Maertens, J., Theunissen, K. & Boogaerts, M. (2002). Invasive aspergillosis: focus on new approaches and new therapeutic agents. Curr Med Chem Anti Infect Agents 1, 65-81.
16. Magnusson, J. & Schnurer, J. (2001). Lactobacillus coryniformis subsp. coryniformis strain Si3 produces a broad-spectrum proteinaceous antifungal compound. Appl Environ Microbiol 67, 1-5.
17. Magnusson, J., Strom, K., Roos, S., Sjogren, J. & Schnurer, J. (2003). Broad and complex antifungal activity among environmental isolates of lactic acid bacteria. FEMS Microbiol Lett 219, 129-135.
18. Matricardi, P. M., Bjorksten, B., Bonini, S. & 8 other authors (2003). Microbial products in allergy prevention and therapy. Allergy 58, 461-471.
19. Ng, T. B. & Parkash, A. (2002). Hispin, a novel ribosome inactivating protein with antifungal activity from hairy melon seeds. Protein Expr Purif 26, 211-217.
20. Rajesh & Sharma, G. L. (2002). Studies on antimycotic properties of Datura metel. J Ethnopharmacol 80, 193-197.
21. Regente, M. C. & de la Canal, L. (2000). Purification, characterization and antifungal properties of a lipid-transfer protein from sunflower (Helianthus annuus) seeds. Physiol Plant 110, 158-163.
22. Richardson, M. D. & Kokki, M. H. (1998). Antifungal therapy in 'bone marrow failure'. Br J Haematol 100, 619-628.
23. Selitrennikoff, C. P. (2001). Antifungal proteins. Appl Environ Microbiol 67, 2883-2894.
24. Sheehan, D. J., Hitchcock, C. A. & Sibley, C. M. (1999). Current and emerging azole antifungal agents. Clin Microbiol Rev 12, 40-79.
25. Smith, P. K., Krohn, R. I., Hermanson, G. T.& 7 other authors (1985). Measurement of protein using bicinchoninic acid. Anal Biochem 150, 76-85.
26. Sorensen, K., Kim, K.-H. & Takemoto, J. Y. (1996). In vitro antifungal and fungicidal activities and erythrocytes toxicities of cyclic lipodepsinonapeptides produced by Pseudomonas syringae pv. syringae. Antimicrob Agents Chemother 40, 2710-2713.
27. Viscoli, C. & Castagnola, E. (1998). Emerging fungal pathogens, drug resistance and the role of lipid formulations of amphotericin B in the treatment of fungal infections in cancer patients: a review. Int J Infect Dis 3, 109-118.
28. Walsh, T. J., Hiemenz, J. W. & Anaissie, E. (1996). Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients. Infect Dis Clin North Am 10, 365-400.
29. Walsh, T. J., Pappas, P., Winston, D. J. & 20 other authors (2002). Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med 346, 225-234.
30. Woo, J. H., Kitamura, E., Myouga, H. & Kamei, Y. (2002). An antifungal protein from the marine bacterium Streptomyces sp. strain AP77 is specific for Pythium porphyrae, a causative agent of red rot disease in Porphyra spp. Appl Environ Microbiol 68, 2666-2675.
31. Ye, X. Y., Wang, H. X. & Ng, T. B. (1999). First chromatographic isolation of an antifungal thaumatin-like protein from French bean legumes and demonstration of its antifungal activity. Biochem Biophys Res Commun 263, 130-134.
32. Ye, X. Y., Wang, H. X. & Ng, T. B. (2000). Sativin, a novel antifungal miraculin-like protein isolated from the legumes of the sugar snap Pisum sativum var. macrocarpon. Life Sci 67, 775-781.
33. York, W. S., Qin, Q. & Rose, J. K. (2004). Proteinaceous inhibitors of endo-beta-glucanases. Biochim Biophys Acta 1696, 223-233.